Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/214450 stock hub

KOSDAQ/214450 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/214450is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5T

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/214450

In the news

Latest news · KOSDAQ/214450

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.6

P25 9.8P50 17.1P75 31.9

Trailing P/E22.8

P25 12P50 23.1P75 39.5

ROE26

P25 -17.1P50 0.7P75 8.5

ROIC48.2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/214450 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

KRW

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	497
Enterprise value	KRW 3.2T
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7214450009
Last refreshed	2026-05-10
Market cap	KRW 3.5T
Price	KRW 341,000
Price currency	KRW
Rev Per Employee	1,079,052,552.94x
Sector	Healthcare
Sic	2836
Symbol	kosdaq/214450
Website	https://pharmaresearch.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.66%
EV Earnings	19.24x
EV/EBIT	15.17x
EV/EBITDA	14.11x
EV/FCF	20.7x
EV/Sales	5.92x
FCF yield	4.33%
Forward P/E	17.59x
P/B ratio	4.89x
P/E ratio	22.84x
P/S ratio	6.61x
PE Ratio10 Y	25.25x
PE Ratio3 Y	24.63x
PE Ratio5 Y	21.73x
PEG ratio	0.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.59%
EBITDA Margin	42.54%
FCF margin	28.61%
Gross margin	76.68%
Gross Profit	KRW 411.2B
Gross Profit Growth	63.68%
Gross Profit Growth Q	44.65%
Gross Profit Growth3 Y	42.7%
Gross Profit Growth5 Y	41.34%
Net Income	KRW 165.1B
Net Income Growth	79.4%
Net Income Growth Q	74.24%
Net Income Growth Quarters	6%
Net Income Growth Years	3%
Net Income Growth3 Y	59.65%
Net Income Growth5 Y	38.18%
Pretax Margin	40.37%
Profit Margin	30.79%
Profit Per Employee	KRW 332.2M
Profitable Years	11
ROA	13.97
Roa5y	10.91
ROCE	22.73
ROE	25.99
Roe5y	17.99
ROIC	48.19
Roic5y	28.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	19.86%
Cagr1y	-9.38%
Cagr3y	51.2%
Cagr5y	38.59%
Div CAGR10	28.56%
Div CAGR3	57.34%
Div CAGR5	43.88%
EPS Growth	67.02
EPS Growth Q	69.35
EPS Growth Quarters	6
EPS Growth Years	3
EPS Growth3 Y	54.27
EPS Growth5 Y	34.07
FCF Growth	50.86%
FCF Growth Q	105.48%
FCF Growth3 Y	53.83%
OCF Growth	32.61%
OCF Growth Q	55.93%
OCF Growth3 Y	45.55%
OCF Growth5 Y	41.41%
Revenue Growth	53.18x
Revenue Growth Q	39.06x
Revenue Growth Quarters	39x
Revenue Growth Years	10x
Revenue Growth3 Y	40.16x
Revenue Growth5 Y	37.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.56
Assets	KRW 1T
Cash	KRW 614.4B
Current Assets	KRW 759.5B
Current Liabilities	KRW 109.8B
Debt	KRW 213B
Debt EBITDA	KRW 0.93
Debt Equity	KRW 0.29
Debt FCF	KRW 1.39
Equity	KRW 724.6B
Interest Coverage	20.43
Liabilities	KRW 319.3B
Long Term Assets	KRW 284.3B
Long Term Liabilities	KRW 209.5B
Net Cash	KRW 401.4B
Net Cash By Market Cap	KRW 11.33
Net Cash Growth	75.6%
Net Debt EBITDA	KRW -1.76
Net Debt Equity	KRW -0.55
Net Debt FCF	KRW -2.62
Tangible Book Value	KRW 658.8B
Tangible Book Value Per Share	KRW 63,410
WACC	7.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.92
Inventory Turnover	1.79
Net Working Capital	KRW 45B
Quick ratio	6.07
Working Capital	KRW 649.7B
Working Capital Turnover	KRW 0.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.34%
Dividend Growth	236.36%
Dividend Growth Years	6%
Dividend per share	KRW 3,700
Dividend Years	11
Dividend Yield	1.09%
Ex Div Date	2025-12-29
Last Dividend	KRW 3,700
Payout Frequency	Annual
Payout Ratio	7.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	511.82%
1Y total return	-9.38%
200-day SMA	462,592.5
3Y total return	245.76%
50-day SMA	314,390
50-day SMA vs 200-day SMA	50under200
5Y total return	411.15%
All Time High	713,000
All Time High Change	-52.17%
All Time High Date	2025-08-26
All Time Low	29,700
All Time Low Change	1,048.15%
All Time Low Date	2020-03-23
ATR	16,930.3
Beta	0.55
Beta1y	0.94
Beta2y	0.34
Ch YTD	-15.38
High	360,500
High52	713,000
High52 Date	2025-08-26
High52ch	-52.17%
Low	330,500
Low52	278,500
Low52 Date	2026-04-07
Low52ch	22.44%
Ma50ch	8.46%
Price vs 200-day SMA	-26.29%
RSI	60.74
RSI Monthly	50.07
RSI Weekly	43.35
Sharpe ratio	0.23x
Sortino ratio	0.39
Total Return	-11.26%
Tr YTD	-15.38
Tr1m	20.71%
Tr1w	0.59%
Tr3m	0.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 212.3B
Operating Income Growth	68.45
Operating Income Growth Q	47.91
Operating Income Growth3 Y	47.69
Operating Income Growth5 Y	44.74
Operating margin	39.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,581,828%
Net Borrowing	-3,369,950,590
Shares Insiders	34.92%
Shares Institutions	16.24%
Shares Out	10,389,648
Shares Qo Q	0%
Shares Yo Y	12.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 153.3B
Average Volume	98,506x
Bv Per Share	66,347.9
CAPEX	KRW -29.7B
Ch10y	465.5
Ch1m	20.71
Ch1w	0.59
Ch1y	-10.26
Ch3m	0.29
Ch3y	238
Ch5y	391.4
Ch6m	-30.19
Change	2.56%
Change From Open	-0.73
Close	332,500
Days Gap	3.31
Depreciation Amortization	15,815,409,500
Dollar Volume	122,705,099,000
Earnings Date	2026-05-08
EBIT	KRW 212.3B
EBITDA	KRW 228.1B
EPS	KRW 14,933
F Score	7
FCF	KRW 153.4B
FCF EV Yield	4.83x
FCF Per Share	KRW 14,768
Financing CF	-15,272,563,390
Fiscal Year End	December
Founded	1,993
Goodwill	12,462,034,000
Graham Number	149305.14676
Graham Upside	-56.22
Income Tax	KRW 48.3B
Investing CF	-155,917,951,220
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2025-12-31
Lynch Fair Value	KRW 373,319
Lynch Upside	9.48
Ma150	408,716.7
Ma150ch	-16.57%
Ma20	315,025
Ma20ch	8.25%
Net CF	10,315,227,730
Next Earnings Date	2026-08-07
Open	343,500
P FCF Ratio	23.09
P OCF Ratio	19.34
Payment Date	2026-04-16
Position In Range	35
Ppne	174,549,327,720
Price Date	2026-05-08
Price EBITDA	KRW 15.53
Ptbv Ratio	5.38
Relative Volume	3.82x
Revenue	536,289,118,810x
SBC By Revenue	0.03x
Share Based Comp	149,422,740
Tax By Revenue	9x
Tax Rate	22.29%
Tr6m	-29.51%
Volume	359,839
Z Score	11.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KOSDAQ/214450 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$3700 annual per share

Payout ratio

+7.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+43.9%

6 consecutive years of growth

Total shareholder yield

-11.3%

Next ex-dividend date: 2025-12-29

Performance

KOSDAQ/214450 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/214450?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.2%

Share of float held by funds and institutions

Insider ownership

+34.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.3%

Negative means the company is buying back shares.

Technical

KOSDAQ/214450 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.7

Neutral momentum band

Price vs 200-day MA

-26.3%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/214450

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/214450 stock rating?

kosdaq/214450 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/214450 analysis?

The full report lives at /stocks/kosdaq/214450/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/214450?

The latest report frames kosdaq/214450 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/214450 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.